These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1092 related articles for article (PubMed ID: 10728801)

  • 21. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
    Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
    J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and treatment of variceal haemorrhage in 2017.
    Brunner F; Berzigotti A; Bosch J
    Liver Int; 2017 Jan; 37 Suppl 1():104-115. PubMed ID: 28052623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Villanueva C; Graupera I; Aracil C; Alvarado E; Miñana J; Puente Á; Hernandez-Gea V; Ardevol A; Pavel O; Colomo A; Concepción M; Poca M; Torras X; Reñe JM; Guarner C
    Hepatology; 2017 May; 65(5):1693-1707. PubMed ID: 28100019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.
    Rockey DC
    Curr Gastroenterol Rep; 2006 Feb; 8(1):7-13. PubMed ID: 16510029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
    Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
    Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Oesophageal Varices in Liver Cirrhosis.
    Sauerbruch T; Wong F
    Digestion; 2019; 99(4):261-266. PubMed ID: 30212817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of portal pressure studies in the management of variceal haemorrhage.
    Addley J; Tham TC; Cash WJ
    World J Gastrointest Endosc; 2012 Jul; 4(7):281-9. PubMed ID: 22816007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg.
    Guo H; Zhang F; Yin X; Zhang M; Xiao J; Wang Y; Zhang B; Zhang W; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1427-1435. PubMed ID: 32868650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
    Villanueva C; Aracil C; Colomo A; Lopez-Balaguer JM; Piqueras M; Gonzalez B; Torras X; Guarner C; Balanzo J
    Aliment Pharmacol Ther; 2009 Feb; 29(4):397-408. PubMed ID: 19006538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis.
    Avgerinos A; Armonis A; Stefanidis G; Mathou N; Vlachogiannakos J; Kougioumtzian A; Triantos C; Papaxoinis C; Manolakopoulos S; Panani A; Raptis SA
    Hepatology; 2004 Jun; 39(6):1623-30. PubMed ID: 15185303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R; Kravetz D; Fassio E; Ameigeiras B; Garcia D; Isla R; Landeira G; Dominguez N; Romero G; Argonz J; Terg R
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding Complications of Portal Hypertension.
    Vashishtha C; Sarin SK
    Clin Liver Dis; 2024 Aug; 28(3):483-501. PubMed ID: 38945639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Variceal upper digestive bleeding--an ever new complication in liver cirrhosis].
    Prelipcean CC; Sporea I; Mihai C; Gogălniceanu P; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):19-26. PubMed ID: 17595842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of portal hypertension and esophageal varices in alcoholic cirrhosis.
    Trevillyan J; Carroll PJ
    Am Fam Physician; 1997 Apr; 55(5):1851-8, 1861-2. PubMed ID: 9105210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
    Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
    Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.